Atlas Trials

Hyperpolarized 13C-MRI and Metabolomics for Immune-related Adverse Events

Clinical trial NCT06243250 · UNKNOWN

Trial details

NCT number
NCT06243250
Sponsor
Chang Gung Memorial Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Immune-related Adverse Event
Start date
2024-02-01
Primary completion
2025-01-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.